Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?


Saygili U., Guclu S., Uslu T., Erten O., Demir N., Onvural A.

GYNECOLOGIC ONCOLOGY, vol.86, no.1, pp.57-61, 2002 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 86 Issue: 1
  • Publication Date: 2002
  • Doi Number: 10.1006/gyno.2002.6719
  • Journal Name: GYNECOLOGIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.57-61
  • Keywords: CA-125, ovarian carcinoma, cytoreduction, debulking, LONG-TERM SURVIVAL, NEOADJUVANT CHEMOTHERAPY, DEBULKING SURGERY, MONOCLONAL-ANTIBODY, RESIDUAL DISEASE, CANCER, MANAGEMENT
  • Dokuz Eylül University Affiliated: No

Abstract

Objective. The aim of this study was to investigate the predictive value of serum CA-125 levels to ability of optimal primary cytoreduction in patients with advanced epithelial ovarian carcinoma.